Search:

China Iron Deficiency Products Market

Report Overview

For decades, iron is widely known to be one of the essential elements for human body. Iron deficiency disease (IDD) is commonly conditions for about 2.0 bil people word widely, in which about 1.2 bil are of iron-deficiency anemia, including pregnant woman, infant and children between 1~2 years old, preschoolers are high risk suffers. In China, the China prevalence rates of IDD in high risk groups are also high.

Unlike its western counterparts, China is a later comer in terms of its development of iron product market. With the pursuit of better quality and healthier lifestyle among Chinese consumers, the market has been catching up at an enormous speed in recent years. Chinese iron diet supplement and medicines crossing three markets: foods, healthy foods and medicines.

Through Loudon’s research effort, this report will put you in the right path of strategic thinking and serve to provide some answers to the frequently asked questions: What is the current market landscape of Iron product, where seems to be the opportunities and challenges amongst all three segment markets, food, healthy foods and medicines, the growing trends and drivers, the segments to be targeted by different products and channels. This report also presents fourteen key iron products in China.

Key Report Features

Overview of Iron in Metabolism and IDD

High risk suffer groups and prevalence

China RDA iron

Three categories of iron supplements, target consumer/high risk suffer groups and adoptions: food, healthy food and medicines

Four generations of iron supplements

Ingredients for foods and healthy foods

Healthy foods iron supplement: formulation, ingredients, functions and target populations

Medicines iron supplement: formulation, ingredients, functions and target populations

Infant nutrition and iron supplement

Key iron products and manufacturers

The report is in about 41 pages in Chinese presentation format. English version will be charged additionally.

Who Would Benefit From This Report?

CEOs

Sales & Marketing VPs

R & D

BD/Marketing/ Medical Directors

Researchers

Financial Analysts in pharmaceutical, medical device, health food, cosmetics

Private and institutional investors in life science industry

Publication date

Feb 1, 2013

Price

7,000 RMB / 1,120 USD per subscription

*You can send E-mail Email to LFE to purchase this report.

Please transfer the RMB or USD payments to the following account:

A/C: Shanghai Loudon Marketing Consultant Co., Ltd
A/C: No. 444259223258
Bank Name: Bank of China Shanghai, FanYu Road Sub-branch
Swift code: BKCHCNBJ300

Name Beneficiary：Loudon Far East B.V. The Netherlands
Bank Name：ING Bank N.V.
Account No：67.38.48.906
IBAN：NL23INGB 0673848906
BIC/SWIFT：INGBNL2A

Step 1:

Please choose the report you are interested in, click "More information" button.

Step 2:

Please go through the brief introduction of the report carefully and click "E-mail" link in the end of the page.

Step 3:

Please finish filling your required information in the e-mail.

Step 4:

After sending E-mail to Loudon, our client service person will contact you afterwards.

*If any questions, please contact our client service person.

Tel: +86-21-6290 2121-107

Email: jenny.zhu@loudon-research.com

(All free during 10:00~18:00 every work-day)